Delivery Order SPE2DB22D3501-SPE2DB25FXM41
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,676.98 to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a firm fixed-price delivery order to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in military and veteran healthcare systems for the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $1,337.70 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication primarily used to treat attention-deficit/hyperactivity disorder...
- The Defense Logistics Agency awarded a delivery order valued at $1,601.50 to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $1,941.61 to AmerisourceBergen Drug Corp for Vyvanse 60 mg capsules (100 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran healthcare systems for...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.17 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.32 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work is to...
- The Defense Logistics Agency awarded a delivery order valued at $2,189.62 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vyvanse 30 mg capsules (100 count). This non-set-aside, firm fixed price delivery order is scheduled for ultimate completion on August 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,337.70 on July 21, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This firm fixed-price delivery order, which is expected to be completed by July 22, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used to treat attention-deficit/hyperactivity disorder and binge...
- The Defense Logistics Agency awarded a delivery order valued at $5,743.58 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) under a firm fixed price contract. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle, with performance to be fulfilled at the contractor's Conshohocken,...